Judgment of the Court (Third Chamber); 12 December 2013. Eli Lilly and Company Ltd v Human Genome Sciences Inc. Request for a preliminary ruling from the High Court of Justice (England and Wales); Chancery Division (Patents Court). Medicinal products for human use — Supplementary protection certificate — Regulation (EC) No 469/2009 — Article 3 — Conditions for obtaining such a certificate — Concept of a ‘product protected by a basic patent in force’ — Criteria — Wording of the claims of the basic patent — Precision and specificity — Functional definition of an active ingredient — Structural definition of an active ingredient — European Patent Convention.